The FDA released its statistics for the last quarter of 2000 and the year ending December 2000. The figures show an impressive18% increase in volume for the full year 2000 over 1999 to Ј77.06bn (Ј65.29bn). This compares with a 13% increase in 1999 over 1998 (Ј56.93bn).
Invoice discounting continues to increase its share of total volume, recording a 21% improvement for the year.
Advances to clients show an even greater increase, with the balance at the end of 2000 reading Ј6,242m, compared with Ј4,972m at the end of 1999 – up 26%.
